India's Anaemia Mukt Bharat Abhiyaan Revamped
Analysis based on 7 articles · First reported Jun 28, 2026 · Last updated Jun 28, 2026
The new guidelines for 'TB Mukt Bharat Abhiyan' in India are expected to positively impact the healthcare sector by driving demand for diagnostic tools, iron supplements, and digital health solutions. Companies involved in these areas, as well as those providing intravenous iron therapies like Ferric Carboxymaltose and Iron Sucrose, may see increased market opportunities.
Union Health Minister J.P. Nadda released new operational guidelines for the 'TB Mukt Bharat Abhiyan' in India. This initiative transitions from 'Anaemia Mukt Bharat' to 'TB Mukt Bharat Abhiyan', reflecting a more comprehensive, people-centric, and technology-enabled approach to combat anaemia. Key changes include an expanded 7x7x7 strategy, introducing Low Birth Weight babies as a new beneficiary group, and a shift from a T3 to a T4 (Test, Treat, Talk, Track) approach. The guidelines also formalize the inclusion of Intravenous Iron Therapy for severe anaemia in pregnant and lactating women and establish a robust digital ecosystem for monitoring anaemia services. This ecosystem will integrate existing portals like JANANI Portal, India — Rashtriya Kishor Swasthya Karyakram, and U-WIN into a unified 'TB Mukt Bharat Abhiyan Portal' for comprehensive tracking and evidence-based planning.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard